Valuation: Paion AG

Market Cap 144K 158K 133K 121K 227K 14.65M 238K 1.62M 642K 8M 594K 581K 25.11M P/E 2021
-3.89x
P/E 2022 -53x
Enterprise Value 9.87M 10.83M 9.09M 8.27M 15.52M 1B 16.31M 111M 43.98M 548M 40.65M 39.79M 1.72B EV / Sales 2021
14.1x
EV / Sales 2022 1.22x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
1 day-2.17%
1 week-2.17%
Current month-11.76%
1 month-18.18%
3 months-2.17%
6 months-66.67%
Current year+240.91%
1 week 0.04
Extreme 0.04500000
0.05
1 month 0.04
Extreme 0.04500000
0.05
Current year 0.01
Extreme 0.012
0.23
1 year 0.01
Extreme 0.012
0.23
3 years 0
Extreme 0.0001
0.36
5 years 0
Extreme 0.0001
16.74
10 years 0
Extreme 0.0001
36.78
Manager TitleAgeSince
Chief Executive Officer 62 2023-08-31
Director of Finance/CFO - 2022-05-31
Director TitleAgeSince
Director/Board Member 65 2012-09-30
Director/Board Member 75 2017-05-31
Director/Board Member - 2019-05-21
Date Insider Type Main position Quantity % Market Cap. Importance
12/27/22 Buy

Director

1,121 0.0016%
1/12/21 Buy

Chief Executive Officer

8,500 0.0127%
6/8/20 Buy

Chief Executive Officer

13,158 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
-2.17%-2.17%+268.85%-52.13% 352K
-2.49%-3.76%+50.31%+62.10% 63.66B
-0.63%-2.91%+6.20%+89.22% 58.56B
-2.37%-2.22%+22.87%+82.31% 54.19B
-2.19%-6.15%+11.92%+108.08% 44.66B
-1.89%-7.28%+13.22%+19.74% 40.51B
-0.93%-0.47%+19.73%+43.75% 36.27B
+1.11%-6.44%+130.68%+641.83% 34.89B
-0.80%+0.61%+77.26%+56.26% 32.26B
-2.17%+16.65%-29.21%+474.05% 31.01B
Average -1.45%-1.42%+57.18%+152.52% 40B
Weighted average by Cap. -1.48%-1.85%+32.16%+150.90%

Financials

2021 2022
Net sales 7.13M 7.83M 6.57M 5.97M 11.21M 725M 11.78M 79.94M 31.77M 396M 29.36M 28.75M 1.24B 33.25M 36.5M 30.64M 27.87M 52.28M 3.38B 54.95M 373M 148M 1.85B 137M 134M 5.79B
Net income -21.79M -23.92M -20.07M -18.26M -34.26M -2.21B -36M -244M -97.1M -1.21B -89.74M -87.85M -3.8B -579K -636K -534K -485K -910K -58.87M -957K -6.49M -2.58M -32.15M -2.39M -2.33M -101M
Net Debt 13.77M 15.12M 12.69M 11.54M 21.65M 1.4B 22.75M 154M 61.37M 765M 56.72M 55.53M 2.4B 9.72M 10.68M 8.96M 8.15M 15.29M 989M 16.07M 109M 43.34M 540M 40.05M 39.21M 1.69B
Logo Paion AG
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
Employees
64
Date Price Change Volume
26-11-20 €0.0450 -2.17% 17,146
26-11-19 €0.0460 0.00% 0
26-11-18 €0.0460 0.00% 0
26-11-17 €0.0460 -1.08% 15,000
26-11-16 €0.0465 +1.09% 3
  1. Stock Market
  2. Stocks
  3. PA8K Stock